U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07840898) titled 'Ethiopian Antimalarial Therapeutic Efficacy Study 2026' on Sept. 14.
Brief Summary: Background: The WHO recommends monitoring the efficacy of antimalarial drugs at least once every two years after implementation. The Ethiopian Public Health Institute (EPHI), the research arm for the Ministry of Health (MOH), has been studying the safety and efficacy of antimalarial drugs for the past two decades. The national malaria diagnosis and treatment guideline of Ethiopia states first-line treatment for uncomplicated Plasmodium falciparum (P. falciparum) infection is artemether-lumefantrine (AL) with a single dose of primaquine (PQ) and for ...